drug prices News

COVID-19 Treatment Remdesivir to Cost Private Insurers $3,120

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. …

Drugmaker Questioned for Nearly Tripling Price of Potential COVID-19 Drug

The chair of a House of Representatives committee and a fellow Democratic committee member on Monday urged Jaguar Health Inc. to reverse recent price hikes of a drug that could be used to treat side effects in COVID-19 patients and …

How Comparing Drug Prices Lowers Costs for Employers and Patients

A University of California at Berkeley study has found that a “reference pricing model” — comparing brand name and generic medications and adjusting co-pays to encourage patients to choose the lowest cost drugs — delivers “significant cost-savings that increase over …

Drugmakers Begin New Year by Raising Prices

Drugmakers including Bristol-Myers Squibb Co., Gilead Sciences Inc., and Biogen Inc. hiked U.S. list prices on more than 50 drugs on Wednesday, bringing total New Year’s Day drug price increases to more than 250, according to data analyzed by healthcare …

Key Finance Committee Senators Unveil Bipartisan Drug Price Bill

The top Republican and Democrat on the U.S. Senate Finance Committee announced a proposal to lower prescription drug prices on Tuesday that could save $100 billion in costs to government healthcare programs, and said the committee would vote on the …

44 States Sue Drug Maker Teva, Alleging Price Fixing Scheme with 19 Other Firms

U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc. of orchestrating a sweeping scheme with 19 other drug companies to inflate drug prices – sometimes by more than 1,000% – and stifle competition for generic drugs, state prosecutors said …

Bipartisan Bill Would Boost Generic Drugs to Lower Prices

A bipartisan group of U.S. senators re-introduced a bill on Tuesday aimed at helping generic drug companies bring out a cheaper version of pharmaceuticals. Makers of branded drugs have long been accused of refusing to provide samples of drugs on …

Cigna CEO Says Ending Benefits Manager Rebates Won’t Harm Commercial Market

The U.S. government’s proposal to eliminate rebates that pharmacy benefit managers receive from drugmakers will not have a meaningful impact on growth, and does not affect the commercial market, Cigna Corp. Chief Executive Officer David Cordani said on Friday. Investors …

Eli Lilly Posts Drug Price on Website But Not in TV Ads

Drugmaker Eli Lilly has started posting price information online for drugs advertised on TV. On Jan. 8, the company began running TV ads for a popular diabetes drug that don’t give the price but direct viewers to the website . …

California Governor Signs Order to Tackle Drug Prices in First Act

Hours into his new job, California Gov. Gavin Newsom signed an executive order on Monday that could dramatically reshape the way prescription drugs are paid for and acquired in the most populous U.S. state. The order, along with another naming …